DAM
ZYNE

Deltec Asset Management’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Deltec Asset Management’s Portfolio ZYNE Stock Details ZYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-475,000
Closed -$606K – 177
2023
Q3 		$606K Buy
+475,000
New +$606K 0.14% 104